Claims-Based Survival Models Have Potential to Aid Prostate Cancer Decision Making
“Most men with early-stage prostate cancer will die with their disease, not from their disease,” Dr Murphy said.
Brain Cancer
BRAIN CANCER ADVISOR
FEATURED CONTENT
-
-
Unlocking the Potential of Biosimilars in Community Oncology
Full adoption of biosimilars will require proper provider and patient education, payer coverage navigation support, and streamlined workflows. -
Can Patient-Derived Organoids Help Oncologists Make Treatment Decisions?
Organoids created from tumor samples have been revolutionizing laboratory research, but they also may begin helping oncologists decide on treatment regimens for patients. -
Immunosuppression Tied to Poor Outcomes in Multiple Cutaneous SCC
Investigators estimated the effects of immunosuppression on poor outcomes in multiple cutaneous squamous cell carcinoma. -
Intravenous Busulfan Plus Melphalan vs Melphalan Alone as a Conditioning Regimen in Multiple Myeloma: Is There a Difference?
There appears to be accumulating evidence to support the routine use of busulfan plus melphalan as a conditioning regimen.
BRAIN CANCER NEWS
Combining CAR-T and BiTE in Models of Glioblastoma Multiforme
Delivery of Alternating Electrical Fields Increases Cell Membrane Permeability in Glioblastoma Multiforme
Contrast-Enhanced MRI Characterization of Brain Cancers
In Mice, Lithium Shown to Reverse Dysfunction Related to Brain Tumor Compression
Liquid Biopsy of Cerebrospinal Fluid Provides Genomic Info on Brain Tumors
Want to read more?
Please login or register first to view this content.
Next post in Brain Cancer
